Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,726 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
New paradigm for radiation in multiple myeloma: lower yet effective dose to avoid radiation toxicity.
Elhammali A, Amini B, Ludmir EB, Gunther JR, Milgrom SA, Pinnix CC, Andraos T, Yoder A, Weber D, Orlowski R, Manasanch E, Patel K, Strati P, Nair R, Lee HC, Thomas S, Iyer S, Kaufmann G, Garg N, Dabaja BS. Elhammali A, et al. Among authors: nair r. Haematologica. 2020 Jul;105(7):e355-e357. doi: 10.3324/haematol.2019.235804. Epub 2020 Jan 9. Haematologica. 2020. PMID: 31919088 Free PMC article. No abstract available.
Radiation therapy for salivary gland MALT lymphoma: ultra-low dose treatment achieves encouraging early outcomes and spares salivary function.
Gunther JR, Park C, Dabaja BS, Milgrom SA, Cruz Chamorro RJ, Medeiros LJ, Khoury JD, Garg N, Amini B, Steiner R, Nair R, Strati P, Westin JR, Lee HJ, Fowler N, Nastoupil L, Neelapu SS, Pinnix CC. Gunther JR, et al. Among authors: nair r. Leuk Lymphoma. 2020 Jan;61(1):171-175. doi: 10.1080/10428194.2019.1644333. Epub 2019 Aug 2. Leuk Lymphoma. 2020. PMID: 31373240 No abstract available.
Pretreatment SUVmax may influence the clinical benefit of BR over R-CHOP in patients with previously untreated FL.
Strati P, Ahmed MA, Nastoupil LJ, Feng L, Hagemeister FB, Fayad LE, Rodriguez MA, Samaniego F, Wang M, Westin JR, Lee HJ, Iyer SP, Parmar S, Ahmed S, Nair R, Steiner RE, Noorani M, Flowers CR, Davis RE, Fowler NH, Neelapu SS. Strati P, et al. Among authors: nair r. Leuk Lymphoma. 2020 Jun;61(6):1380-1387. doi: 10.1080/10428194.2020.1716221. Epub 2020 Jan 23. Leuk Lymphoma. 2020. PMID: 31971032
Imaging Surveillance of Limited-stage Classic Hodgkin Lymphoma Patients After PET-CT-documented First Remission.
Glober G, Gunther J, Fang P, Milgrom S, Korivi BR, Jensen CT, Wagner-Bartak NA, Ahmed S, Lee HJ, Nair R, Steiner R, Parmar S, Iyer S, Westin J, Fayad L, Rodriguez MA, Neelapu S, Nastoupil L, Flowers CR, Dabaja BS, Pinnix CC. Glober G, et al. Among authors: nair r. Clin Lymphoma Myeloma Leuk. 2020 Aug;20(8):533-541. doi: 10.1016/j.clml.2020.02.008. Epub 2020 Feb 20. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32291233 Free PMC article.
Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma.
Pinnix CC, Gunther JR, Dabaja BS, Strati P, Fang P, Hawkins MC, Adkins S, Westin J, Ahmed S, Fayad L, Lee HJ, Nair R, Steiner RE, Iyer SP, Rodriguez MA, Wang M, Flowers C, Neelapu SS, Nastoupil LJ. Pinnix CC, et al. Among authors: nair r. Blood Adv. 2020 Jul 14;4(13):2871-2883. doi: 10.1182/bloodadvances.2020001837. Blood Adv. 2020. PMID: 32589728 Free PMC article.
Clinical efficacy of anakinra to mitigate CAR T-cell therapy-associated toxicity in large B-cell lymphoma.
Strati P, Ahmed S, Kebriaei P, Nastoupil LJ, Claussen CM, Watson G, Horowitz SB, Brown ART, Do B, Rodriguez MA, Nair R, Shpall EJ, Green MR, Neelapu SS, Westin JR. Strati P, et al. Among authors: nair r. Blood Adv. 2020 Jul 14;4(13):3123-3127. doi: 10.1182/bloodadvances.2020002328. Blood Adv. 2020. PMID: 32645136 Free PMC article. No abstract available.
Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphoma.
Strati P, Nastoupil LJ, Westin J, Fayad LE, Ahmed S, Fowler NH, Hagemeister FB, Lee HJ, Iyer SP, Nair R, Parmar S, Rodriguez MA, Samaniego F, Steiner RE, Wang M, Pinnix CC, Adkins S, Claussen CM, Martinez CS, Hawkins MC, Johnson NA, Singh P, Mistry HE, Horowitz S, George S, Feng L, Kebriaei P, Shpall EJ, Neelapu SS, Tummala S, Chi TL. Strati P, et al. Among authors: nair r. Blood Adv. 2020 Aug 25;4(16):3943-3951. doi: 10.1182/bloodadvances.2020002228. Blood Adv. 2020. PMID: 32822484 Free PMC article.
Partial omission of bleomycin for early-stage Hodgkin lymphoma patients treated with combined modality therapy: Does incomplete ABVD lead to inferior outcomes?
Gunther JR, Pinnix CC, Glober GR, Christopherson KM, Fang P, Lee HJ, Ahmed S, Steiner RE, Nair R, Strati P, Neelapu SS, Nastoupil LJ, Dabaja BS. Gunther JR, et al. Among authors: nair r. EJHaem. 2020 Jul;1(1):272-276. doi: 10.1002/jha2.1. Epub 2020 Feb 7. EJHaem. 2020. PMID: 32864660 Free PMC article.
Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy.
Pinnix CC, Gunther JR, Fang P, Bankston ME, Milgrom SA, Boyce D, Lee HJ, Nair R, Steiner R, Strati P, Ahmed S, Iyer SP, Westin J, Parmar S, Rodriguez MA, Nastoupil L, Neelapu S, Flowers C, Dabaja BS. Pinnix CC, et al. Among authors: nair r. JAMA Netw Open. 2020 Sep 1;3(9):e2013935. doi: 10.1001/jamanetworkopen.2020.13935. JAMA Netw Open. 2020. PMID: 32990738 Free PMC article.
2,726 results